Normal view MARC view ISBD view

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.

Kloos, Robin Q H

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model. [electronic resource] - Haematologica 05 2021 - 1254-1261 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1592-8721

Standard No.: 10.3324/haematol.2019.242289 doi

Subjects--Topical Terms:
Asparaginase
Child
Databases, Factual
Drug Monitoring
Humans
Models, Biological
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)